| Vol. 15.06 – 16 February, 2023 |
| |
|
|
| Researchers identified an unexpected protein vulnerability in p53-inactivated TNBC and designed a new PROTAC to target it. [Cancer Discovery] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Investigators reported that the long noncoding RNA (lncRNA) BREA2 drove breast cancer metastasis by stabilizing the Notch1 intracellular domain. [Proceedings Of The National Academy Of Sciences Of The United States Of America] |
|
|
|
| Scientists investigated the role of Plk4 in carcinogenesis and showed that its overexpression significantly potentiated resistance to cell death by anoikis of nontumorigenic p53 knock-out (p53KO) mammary epithelial cells. [Cell Death & Disease] |
|
|
|
| Researchers found that DNA methyltransferases (DNMT) 3a-mediated dermatopontin (DPT) promoter hypermethylation resulted in the downregulation of DPT expression in breast cancer and its low expression correlated with poor prognosis. [Cell Death & Disease] |
|
|
|
| The authors discovered that COX-2, a target gene of C/EBPd, or its metabolite prostaglandin E2 promoted protein stability of E-cadherin, β-catenin, and p120 catenin through inhibition of GSK3β. [JCI Insight] |
|
|
|
| Scientists assessed the mechanisms of acquired resistance using T47D and MCF-7 tamoxifen- and palbociclib-resistant cell-line variants in culture and as xenografts, and patient-derived cells obtained from sensitive or resistant patient-derived xenografts. [Scientific Reports] |
|
|
|
| Investigators elucidated the effect of epigenetic alterations on centrosome amplification, epithelial-mesenchymal transition, and apoptosis in TNBC adenocarcinoma derived MDA-MB-231 cell line. [Scientific Reports] |
|
|
|
| Researchers explored protein-lipid interactions using lipidomic and mass spectrometry approaches to better understand the molecular determinants of anti-cancer peptide selectivity. [Biophysical Journal] |
|
|
|
| The authors developed experimental and analytical approaches that allowed them to monitor polarized membrane trafficking, the formation of adhesive structures, and membrane tension in several migrating breast epithelial cell lines. [Biophysical Journal] |
| |
|
|
|
| Scientists give an overview of Yes-associated protein (YAP)/transcriptional coactivator with PDZ-binding motif (TAZ)-mediated oncogenesis in breast cancer (BC), and then systematically summarize the oncogenic roles of YAP/TAZ in various BC subtypes, BC stem cells, and tumor microenvironments. [British Journal of Cancer] |
|
|
|
| Investigators provide an overview of immunotherapies currently under clinical development and updated key results from clinical trials. [npj Breast Cancer] |
|
|
|
|
| Baylor College of Medicine has been awarded more than $5.8 million in grants by the Cancer Prevention & Research Institute of Texas (CPRIT) to support innovative translational research and cancer treatments. [Baylor College of Medicine] |
|
|
|
| Miranda Steeves, a graduate student at the University of Prince Edward Island (UPEI), is working on breast cancer research, with assistance from $11,900 in funding provided by the Canadian Cancer Society’s J.D. Irving, Limited—Excellence in Cancer Research Fund. [University of Prince Edward Island] |
|
|
|
|
| March 31, 2023 Amsterdam, The Netherlands |
|
|
|
|
|
| University of Texas Health Science Center – San Antonio, Texas United States |
|
|
|
| Institute of Cancer Research – London, England, United Kingdom |
|
|
|
| Duke University – Durham, North Carolina, United States |
|
|
|
| Vanderbilt-Ingram Cancer Center – Nashville, Tennessee, United States |
|
|
|
| University of Mississippi Medical Center – Jackson, Mississippi, United States |
|
|
|
|